Cancer Stem Cells Activate STAT3 the EZ Way

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Signal transducer and activator of transcription 3 (STAT3) activation and increased enhancer of zeste homolog 2 (EZH2) expression are linked to aggressive gliomas.
• Gliomas are primary brain tumors with a significant malignant subset.

Purpose of the Study:

• To investigate the functional relationship between EZH2 and STAT3 in glioma pathogenesis.
• To determine if EZH2 directly influences STAT3 activation and its role in glioma stem-like cells.

Main Methods:

• The study utilized molecular biology techniques to assess EZH2 and STAT3 interactions.
• Specific experiments focused on EZH2's enzymatic activity, including trimethylation of STAT3.
• Analysis was performed in glioma stem-like cells to understand cell-specific effects.

Main Results:

• Kim and colleagues found that EZH2 directly enhances STAT3 activation.
• EZH2 trimethylates lysine180 on STAT3, leading to its activation.
• This EZH2-mediated STAT3 activation is preferentially observed in glioma stem-like cells.

Conclusions:

• EZH2 plays a crucial role in promoting STAT3 activation within malignant gliomas.
• The trimethylation of STAT3 by EZH2 is a key mechanism driving glioma progression, especially in stem-like cells.
• Targeting the EZH2-STAT3 interaction may offer a novel therapeutic strategy for aggressive gliomas.